Table 5.
Serum levels of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and nitric oxide levels after 28 days of treatment.
| Treatment | TG (mg/dL) | TC (mg/dL) | HDL (mg/dL) | LDL (mg/dL) | Nitric Oxide (ng/mL) |
|---|---|---|---|---|---|
| Control | 90.0 ± 2.0 | 99.5 ± 1.5 | 28.0 ± 1.1 | 58.0 ± 1.2 | 6.5 ± 0.4 |
| Paraxanthine | 82.5 ± 2.7 **$% | 87.8 ± 2.3 **$%# | 32.0 ± 0.8 **$&% | 52.8 ± 3.9 * | 13.1 ± 0.6 **$%# |
| L-Theanine | 88.1 ± 3.7 | 90.6 ± 2.7 | 29.1 ± 2.5 | 55.3 ± 4.1 | 10.2 ± 1.3 |
| Alpha-GPC | 88.4 ± 3.5 | 93.9 ± 4.5 | 28.4 ± 1.4 | 56.3 ± 2.3 | 9.2 ± 2.3 |
| Taurine | 90.4 ± 2.5 | 96.0 ± 4.3 | 28.4 ± 1.1 | 56.8 ± 2.2 | 7.6 ± 0.3 |
Data are the mean ± SD for n = 8 mice in each group. * p < 0.05 vs. control, ** p < 0.001 vs. control, $ = p < 0.001 vs. alpha-GPC, % = p < 0.001 vs. taurine, & = p < 0.05 vs. L-theanine, # = p < 0.001 vs. L-theanine.